PortViewPortView
Alvotech logo

Alvotech (ALVOW) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$0.32-18.77%
1-year price historyRange $0.13 – $2.66
52-week range$0.32
$0.32$1.52

What Alvotech does

Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.

Key metrics

Market cap
$3.02B
P/E (TTM)
47.36
EPS (TTM)
$0.01
Beta
0.19
Dividend yield
0.00%
Revenue / share
$1.38
50-day avg
$0.24
200-day avg
$0.55
52-week high
$1.52
52-week low
$0.32
CEO
Lisa Graver

ETFs linked to ALVOW

Broad-market and Healthcare sector ETFs an investor holding Alvotech is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ALVOW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALVOW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Alvotech?
Alvotech trades under the ticker ALVOW on NASDAQ.
Which exchange is ALVOW listed on?
ALVOW is listed on NASDAQ.
What sector does Alvotech operate in?
Alvotech is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze ALVOW in a portfolio?
PortView shows ALVOW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.